Skip to content

Dr. Brown's Home Drug Testing Kit

by Personal Health & Hygiene, Inc.

PMA P950040

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P950040↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP950040 Date21 Jan 1997ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
Enzyme immunoassay, cannabinoids
PMA Number
FDA Product Code
LDJ
Device Class
Class II
Regulation
21 CFR Part 862.3870
Advisory Committee
Clinical Toxicology
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is an enzyme immunoassay for cannabinoids, designed to detect the presence of cannabinoid metabolites in urine samples. It functions as a rapid, qualitative test to screen for drug use, providing results within minutes without requiring laboratory processing.

The kit is intended for home use and is supplied as a single-use, non-sterile diagnostic tool. It is classified as a Class II medical device under FDA regulations and requires approval for labeling. No MRI safety information is provided, and the device must be stored according to manufacturer instructions to maintain its integrity until use.

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the DR. BROWN'S HOME DRUG TESTING KIT used for and how does it work?

    The DR. BROWN'S HOME DRUG TESTING KIT is an enzyme immunoassay designed to detect cannabinoid metabolites in urine samples, serving as a rapid, qualitative screening tool for drug use. It provides results within minutes without needing lab processing, making it ideal for home use to screen for recent cannabinoid exposure.

  • Is this device intended for single-use or can it be reused?

    The DR. BROWN'S HOME DRUG TESTING KIT is explicitly labeled as a single-use device. Reuse is not recommended or supported by the manufacturer, as it could compromise accuracy and reliability.

  • How should I store the DR. BROWN'S HOME DRUG TESTING KIT before use?

    The kit must be stored according to the manufacturer’s instructions to maintain its integrity until use. Since it is non-sterile and intended for home use, storage conditions likely include protection from extreme temperatures, moisture, and direct sunlight, though exact details are not specified in the provided data.

  • What regulatory approval does this device have, and how does that affect its use?

    The DR. BROWN'S HOME DRUG TESTING KIT holds an FDA Premarket Approval (PMA) under PMA number P950040, confirming it meets regulatory standards for Class II medical devices. This approval ensures the device’s labeling and intended use comply with FDA requirements, but it does not imply clinical efficacy or diagnostic accuracy beyond its specified purpose—qualitative screening for cannabinoid metabolites.

  • Can this kit be used in professional or clinical settings, or is it strictly for home use?

    The device is explicitly designed for home use and is not marketed or approved for professional or clinical settings. While it may be used in non-laboratory environments like schools or workplaces, its regulatory classification and labeling emphasize its role as a consumer-grade screening tool, not a definitive diagnostic tool.